Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Jul 27 (Reuters)-  
             Takara Bio Inc.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             6.31                5.76             31.00     
                 (+9.5 pct)          (+20.5 pct)      (+4.3 pct)   
  Operating        643 mln             111 mln            2.70     
                (+476.3 pct)         (+70.8 pct)      (+1.2 pct)   
  Recurring        653 mln             217 mln            3.05     
                (+200.2 pct)        (+112.7 pct)      (-7.6 pct)   
  Net              285 mln           loss 36 mln          1.30     
                                                      (-2.6 pct)   
  EPS             2.37 yen          loss 0.30 yen      10.80 yen   
  Ann Div                             1.80 yen         1.80 yen    
  -Q2 div                                NIL              NIL      
  -Q4 div                             1.80 yen         1.80 yen    
   
  NOTE - Takara Bio Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Takara Bio

See all news